Novartis AG
NVSNYSEHealthcare● Active
$146.42
$-2.74(-1.84%)
Market Cap$279.4B
P/E Ratio—
52W High$170.46
52W Low$112.34
Novartis AG (NVS) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NVS · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $14.06B | $11.94B | $8.57B | $6.05B | $22.91B |
| Depreciation & Amort. | $5.35B | $6.07B | $8.28B | $6.71B | $5.60B |
| Stock-Based Comp. | $0.00B | $1.04B | $0.86B | $0.79B | $0.70B |
| Change in Working Capital | ($3.08B) | ($0.71B) | ($0.37B) | ($0.80B) | ($0.07B) |
| Net Cash from Operations | $19.24B | $17.62B | $14.46B | $14.24B | $15.07B |
| Investing Activities | |||||
| Capital Expenditure | ($1.56B) | ($3.81B) | ($2.75B) | ($2.24B) | ($2.56B) |
| Purchases of Investments | ($0.30B) | ($3.65B) | ($0.75B) | ($34.81B) | ($16.59B) |
| Sales of Investments | $2.19B | $3.70B | $11.60B | $39.49B | $2.74B |
| Net Cash from Investing | ($4.90B) | ($7.51B) | $5.60B | $1.47B | $4.21B |
| Financing Activities | |||||
| Common Stock Repurchased | ($9.26B) | ($8.33B) | ($8.72B) | ($10.65B) | ($3.06B) |
| Dividends Paid | ($7.86B) | ($7.62B) | ($7.25B) | ($7.51B) | ($7.37B) |
| Debt Issued / Repaid | $2.72B | $4.39B | ($1.94B) | ($2.58B) | ($5.67B) |
| Net Cash from Financing | ($14.94B) | ($11.74B) | ($14.28B) | ($20.56B) | ($16.26B) |
| Free Cash Flow | |||||
| Free Cash Flow | $17.69B | $13.80B | $11.71B | $12.00B | $12.52B |
| FCF Margin %(computed) | 32.27% | 26.69% | 25.09% | 27.60% | 28.46% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Novartis AG data
About Novartis AG (NVS) Cash Flow Statement
Novartis AG generated operating cash flow of $19.24B and free cash flow of $17.69B for 2025 — a FCF margin of 32.27%. Capital expenditure was ($1.56B).
Frequently asked questions
NVS · 4 questionsNovartis AG generated free cash flow of $17.69B for 2025, up 28.1% year-over-year.
NVS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10